- Home
- IFRX vs DVLT Comparison
IFRX vs DVLT Comparison
Compare IFRX & DVLT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IFRX
- DVLT
- Stock Information
- Founded
- IFRX 2007
- DVLT 2010
- Country
- IFRX Germany
- DVLT United States
- Employees
- IFRX N/A
- DVLT N/A
- Industry
- IFRX Biotechnology: Pharmaceutical Preparations
- DVLT
- Sector
- IFRX Health Care
- DVLT
- Exchange
- IFRX Nasdaq
- DVLT NYSE
- Market Cap
- IFRX 53.5M
- DVLT 55.7M
- IPO Year
- IFRX 2017
- DVLT N/A
- Fundamental
- Price
- IFRX $0.87
- DVLT $0.66
- Analyst Decision
- IFRX Strong Buy
- DVLT Strong Buy
- Analyst Count
- IFRX 4
- DVLT 1
- Target Price
- IFRX $7.75
- DVLT $3.00
- AVG Volume (30 Days)
- IFRX 359.0K
- DVLT 5.0M
- Earning Date
- IFRX 08-07-2025
- DVLT 08-13-2025
- Dividend Yield
- IFRX N/A
- DVLT N/A
- EPS Growth
- IFRX N/A
- DVLT N/A
- EPS
- IFRX N/A
- DVLT N/A
- Revenue
- IFRX $140,242.00
- DVLT $3,048,000.00
- Revenue This Year
- IFRX N/A
- DVLT $434.03
- Revenue Next Year
- IFRX $1,276.37
- DVLT $221.43
- P/E Ratio
- IFRX N/A
- DVLT N/A
- Revenue Growth
- IFRX 30.90
- DVLT 63.08
- 52 Week Low
- IFRX $0.71
- DVLT $0.55
- 52 Week High
- IFRX $2.82
- DVLT $3.25
- Technical
- Relative Strength Index (RSI)
- IFRX 45.31
- DVLT N/A
- Support Level
- IFRX $0.82
- DVLT N/A
- Resistance Level
- IFRX $0.93
- DVLT N/A
- Average True Range (ATR)
- IFRX 0.06
- DVLT 0.00
- MACD
- IFRX 0.02
- DVLT 0.00
- Stochastic Oscillator
- IFRX 33.94
- DVLT 0.00
About IFRX InflaRx N.V.
InflaRx NV is a clinical-stage biopharmaceutical company focused on applying proprietary anti-C5a/C5aR technology to discover and develop first-in-class, potent, and specific inhibitors of the complement activation factor known as C5a and its receptor known as C5aR. C5a is an inflammatory mediator involved in the progression of a wide variety of autoimmune and other inflammatory diseases. Its product candidate, vilobelimab, is a novel intravenously delivered first-in-class anti-C5a monoclonal antibody that selectively binds to free C5a and has demonstrated disease-modifying clinical activity and tolerability in multiple clinical settings.
About DVLT DATAVAULT AI INC
Datavault AI Inc is a data technology and licensing company that enables clients and strategic partners to monetize their Blockchain Data and AI Web 3.0 assets via tokenization, data ownership and digital twins offering two solutions: Data Science licenses High-Performance Computing (HPC) software applications and Web 3.0 data management serving the biotech, energy, education, fintech, real estate, and healthcare industries, among others. Acoustic Science licenses spatial and multichannel HD sound transmission, including proprietary brands ADIO, WiSA and Sumerian, to customers in sports & entertainment, events & venues, restaurants, automotive, finance, and other industries.